Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic Review

Changes to registration elements and results in a cohort of Clinicaltrials.gov trials were not reflected in published articles

(2016) Shelly Pranić et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Reporting of harms outcomes: a comparison of journal publications with unpublished clinical study reports of orlistat trials

(2016) Alex Hodkinson et al.   Trials

Comparison of serious adverse events posted at ClinicalTrials.gov and published in corresponding journal articles

(2015) Eve Tang et al.   BMC Medicine

Compliance with Results Reporting at ClinicalTrials.gov

(2015) Monique L. Anderson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports

(2015) M. Kohler et al.   BMJ-British Medical Journal

Are manufacturers sharing data as promised?

(2015) Evan Mayo-Wilson et al.   BMJ-British Medical Journal

Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence

(2015) Joanna Le Noury et al.   BMJ-British Medical Journal

Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports

(2015) M. Kohler et al.   BMJ-British Medical Journal

Are manufacturers sharing data as promised?

(2015) Evan Mayo-Wilson et al.   BMJ-British Medical Journal

Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence

(2015) Joanna Le Noury et al.   BMJ-British Medical Journal

Reporting Discrepancies Between the ClinicalTrials.gov Results Database and Peer-Reviewed Publications

(2014) Daniel M. Hartung et al.   ANNALS OF INTERNAL MEDICINE

Impact of Inclusion of Industry Trial Results Registries as an Information Source for Systematic Reviews

(2014) Regine Potthast et al.   PLoS One

Differences in reporting serious adverse events in industry sponsored clinical trial registries and journal articles on antidepressant and antipsychotic drugs: a cross-sectional study

(2014) S. Hughes et al.   BMJ Open

Dabigatran: how the drug company withheld important analyses

(2014) D. Cohen   BMJ-British Medical Journal

US Food and Drug Administration documents can provide unpublished evidence relevant to systematic reviews

(2013) Marian S. McDonagh et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Some improvements are apparent in identifying adverse effects in systematic reviews from 1994 to 2011

(2013) Su Golder et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Aspirin Therapy and Risk of Subdural Hematoma: Meta-analysis of Randomized Clinical Trials

(2013) Ben J. Connolly et al.   Journal of Stroke & Cerebrovascular Diseases

Reporting of harms data in RCTs: a systematic review of empirical assessments against the CONSORT harms extension

(2013) Alex Hodkinson et al.   BMJ Open

Reporting of industry funded study outcome data: comparison of confidential and published data on the safety and effectiveness of rhBMP-2 for spinal fusion

(2013) M. A. Rodgers et al.   BMJ-British Medical Journal

Timing and Completeness of Trial Results Posted at ClinicalTrials.gov and Published in Journals

(2013) Carolina Riveros et al.   PLOS MEDICINE

Completeness of Reporting of Patient-Relevant Clinical Trial Outcomes: Comparison of Unpublished Clinical Study Reports with Publicly Available Data

(2013) Beate Wieseler et al.   PLOS MEDICINE

The effect of linagliptin on glycaemic control and tolerability in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

(2012) D. Singh-Franco et al.   DIABETES OBESITY & METABOLISM

The Evolution of Trial Registries and Their Use to Assess the Clinical Trial Enterprise

(2012) Kay Dickersin   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience

(2012) Peter Doshi et al.   PLOS MEDICINE

A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned

(2011) Eugene J. Carragee et al.   Spine Journal

Insomnia medication: Do published studies reflect the complete picture of efficacy and safety?

(2010) Taina Mattila et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Unpublished data can be of value in systematic reviews of adverse effects: methodological overview

(2010) Su Golder et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

The quality of safety reporting in trials is still suboptimal: Survey of major general medical journals

(2010) Anna-Bettina Haidich et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Reporting of Safety Results in Published Reports of Randomized Controlled Trials

(2009)   ARCHIVES OF INTERNAL MEDICINE

Searching for unpublished trials in Cochrane reviews may not be worth the effort

(2009) Mieke L. van Driel et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies?

(2008) Su Golder et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

AHRQ Series Paper 4: Assessing harms when comparing medical interventions: AHRQ and the Effective Health-Care Program

(2008) Roger Chou et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal